Intrexon Corp., a biology engineering and industrialization firm is refocusing the company on healthcare and changing its name to Precigen, Inc. Helen Sabzevari, PhD, has been appointed president and chief executive officer of Precigen, which will encompass Intrexon’s wholly-owned healthcare subsidiaries Precigen, ActoBio Therapeutics, Exemplar Genetics, and its majority interest in Triple-Gene, as well as interests in therapeutics and therapeutic platforms from companies not controlled by...